The study tested out a new pancreatic cancer therapy, which was tested on mice and found to be effective in killing advanced pancreatic cancer cells. The pancreatic cancer therapy is a new development on an existing treatment, called CAR T-cell immunotherapy. CAR T-cell immunotherapy works by collecting a patient’s T-Cells, modifying them in a lab and injecting them back into the patient so that they can recognise cancer cells.
While it has been successful in treating some leukaemia cases and lymphomas, it only has a limited success in treating tumours. Read more . . .